Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RolE of High Velocity Nasal Insufflation in imrpoVing wEaning Success in Respiratory Failure Patients (REVIVER)

NCT05855213 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT05855213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05855213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RolE of High Velocity Nasal Insufflation in imrpoVing wEaning Success in Respiratory Failure Patients (REVIVER)
Lead sponsor
Alexandria University
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2023
Completion date
July 31, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory failure, weaning failure